These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 12756644)

  • 21. Receptor imaging by positron emission tomography and single-photon emission computed tomography.
    Frost JJ
    Invest Radiol; 1992 Dec; 27 Suppl 2():S54-8. PubMed ID: 1334949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging brain function in animals to understand drugs of abuse and potential pharmacotherapies.
    Piercey MF
    NIDA Res Monogr; 1994; 138():25-40. PubMed ID: 7603543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology.
    Malizia AL
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):100-7. PubMed ID: 16785278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET and SPECT in drug and substance abuse.
    Mena JC; Cuellar H; Vargas D; Riascos R
    Top Magn Reson Imaging; 2005 Jun; 16(3):253-6. PubMed ID: 16340650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia.
    Van Heertum RL; Tikofsky RS
    Semin Nucl Med; 2003 Jan; 33(1):77-85. PubMed ID: 12605358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addiction.
    Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ
    Br Med Bull; 2003; 65():209-22. PubMed ID: 12697627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.
    Erritzoe D; Talbot P; Frankle WG; Abi-Dargham A
    Neuroimaging Clin N Am; 2003 Nov; 13(4):817-32. PubMed ID: 15024964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography in studies of drug abuse.
    London ED
    NIDA Res Monogr; 1994; 138():15-24. PubMed ID: 7603540
    [No Abstract]   [Full Text] [Related]  

  • 30. Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them?
    Busatto GF
    Eur J Nucl Med; 1996 Aug; 23(8):867-70. PubMed ID: 8753673
    [No Abstract]   [Full Text] [Related]  

  • 31. Positron emission tomography and single photon emission computed tomography in epilepsy care.
    Henry TR; Van Heertum RL
    Semin Nucl Med; 2003 Apr; 33(2):88-104. PubMed ID: 12756642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Outlines of interdisciplinary addiction research given by the example of medical imaging with PET, SPECT and fMRI regarding effects of psychotropic substances].
    Giacomuzzi SM; Golaszewski S; Ertl M; Riemer Y; Brandauer E; Ennemoser O; Rössler H; Hinterhuber H
    Neuropsychiatr; 2010; 24(4):224-33. PubMed ID: 21176703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging and mechanisms of drug abuse: interface of molecular imaging and molecular genetics.
    Ernst M; Kimes AS; Jazbec S
    Neuroimaging Clin N Am; 2003 Nov; 13(4):833-49. PubMed ID: 15024965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered prefrontal dopaminergic function in chronic recreational ketamine users.
    Narendran R; Frankle WG; Keefe R; Gil R; Martinez D; Slifstein M; Kegeles LS; Talbot PS; Huang Y; Hwang DR; Khenissi L; Cooper TB; Laruelle M; Abi-Dargham A
    Am J Psychiatry; 2005 Dec; 162(12):2352-9. PubMed ID: 16330601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'.
    Di Chiara G
    Behav Pharmacol; 2002 Sep; 13(5-6):371-7. PubMed ID: 12394413
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychopharmacology--in vivo neurochemistry and pharmacology.
    Grasby P; Malizia A; Bench C
    Br Med Bull; 1996 Jul; 52(3):513-26. PubMed ID: 8949254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPECT imaging in psychiatry: introduction and overview.
    Weinberger DR
    J Clin Psychiatry; 1993 Nov; 54 Suppl():3-5. PubMed ID: 8270596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.
    Gould RW; Porrino LJ; Nader MA
    Curr Top Behav Neurosci; 2012; 11():25-44. PubMed ID: 22020537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN
    Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.